following results due in Sept 06 - this may kick the sp.
quote:
"Media Release March 6, 2006
Eiffel Technologies enters collaboration with Nanotechnology Victoria towards advanced transdermal drug delivery
Sydney, Australia. -- Eiffel Technologies Limited (ASX: EIF) announced today that it has entered into a collaboration with Nanotechnology Victoria (“NanoVic”) to evaluate the application of Eiffel’s intellectual property to the production of nanomaterials suitable for transdermal delivery. This is the first collaborative project to be undertaken by Eiffel in the field of transdermal drug delivery.
Under the agreement, NanoVic will provide funding of $125,000 to Eiffel for the development of nanosphere particulate formulations of therapeutic proteins. Development-scale batches will then be provided to NanoVic for evaluation of delivery performance using advanced transdermal drug delivery systems under development by NanoVic and its collaborators at Monash University College of Pharmacy and MiniFAB.
The work is expected to take approximately six months and further commercial discussions will be held once the results of the preliminary studies are available."
DYOR - I hold at a loss.
- Forums
- ASX - By Stock
- EIF
- reasons to keep faith
EIF
eiffel technologies limited
reasons to keep faith, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online